Realty Income Has Made 650 Consecutive Monthly Payments and the Streak Looks Secure
247wallst.com
Want to monitor IMVT?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor IMVTImmunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.